Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/14760584.2021.1965884 http://scihub22266oqcxt.onion/10.1080/14760584.2021.1965884 34365880!8425431!34365880     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Vaccines 2021 ; 20 (9): 1059-1063 Nephropedia Template TP {{tp|p=34365880|t=2021. Sars-Cov-2 virus and vaccination; biological and statistical framework |pdf=|usr=}}{{34365880}} gab.com Text Sars-Cov-2 virus and vaccination; biological and statistical framework JO: Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=34365880 #FOAvip INTRODUCTION: The Development of the SARS-CoV-2 virus vaccine and its update on an ongoing pandemic is the first subject of the world health agenda. AREAS COVERED: First, we will scrutinize the biological features of the measles virus (MV), variola virus (smallpox virus), influenza virus, and their vaccines to compare them with the SARS-CoV-2 virus and vaccine. Next, we will discuss the statistical details of measuring the effectiveness of an improved vaccine. EXPERT OPINION: Amidst the pandemic, we ought to acknowledge our prior experiences with respiratory viruses and vaccines. In the planning stage of observational Phase-III vaccine effectiveness studies, the sample size, sampling method, statistical model, and selection of variables are crucial in obtaining high-quality and valid results. Twit Text FOAVip Sars-Cov-2 virus and vaccination; biological and statistical framework ????Expert Rev Vaccines http://www.kidney.de/pget.php?&tw=1&pmid=34365880 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34365880 #FOAvip English Wikipedia <ref>{{Cite pmid|34365880}}</ref> Sars-Cov-2 virus and vaccination; biological and statistical framework #MMPMID34365880 Arslan F; Ankarali H Expert Rev Vaccines 2021[Sep]; 20 (9): 1059-1063 PMID34365880show ga INTRODUCTION: The Development of the SARS-CoV-2 virus vaccine and its update on an ongoing pandemic is the first subject of the world health agenda. AREAS COVERED: First, we will scrutinize the biological features of the measles virus (MV), variola virus (smallpox virus), influenza virus, and their vaccines to compare them with the SARS-CoV-2 virus and vaccine. Next, we will discuss the statistical details of measuring the effectiveness of an improved vaccine. EXPERT OPINION: Amidst the pandemic, we ought to acknowledge our prior experiences with respiratory viruses and vaccines. In the planning stage of observational Phase-III vaccine effectiveness studies, the sample size, sampling method, statistical model, and selection of variables are crucial in obtaining high-quality and valid results. |COVID-19 Vaccines/*immunology[MESH] |COVID-19/pathology/*prevention & control[MESH] |Humans[MESH] |Immunity, Cellular/*immunology[MESH] |Influenza Vaccines/immunology[MESH] |Mass Vaccination/methods[MESH] |Measles virus/immunology[MESH] |Measles-Mumps-Rubella Vaccine/immunology[MESH] |Orthomyxoviridae/immunology[MESH] |SARS-CoV-2/*immunology[MESH] |Smallpox Vaccine/immunology[MESH] |Vaccination[MESH] |Vaccines, Attenuated/immunology[MESH]Sars-Cov-2 virus and vaccination; biological and statistical framework(epmc).pdf DeepDyve Pubget Overpricing